IP Library Granted Patent US 9,902,989
Granted Patent B2
US 9,902,989 · App. 14/745,722 · Granted Feb 27, 2018

Methods for the detection of beta-lactamases

Inventors: Mei Yang-Woytowitz (Baltimore, MD); Charles Yu (Lutherville, MD); Timothy Wiles (Manchester, MD)
Assignee: Becton, Dickinson and Company
C12Q1/34C12Q1/04G01N2333/986
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,902,989
App. No.
14/745,722
Granted
Feb 27, 2018
Kind
B2
Abstract

Presented herein are methods and compositions for the detection of specific beta-lactamases, including class A serine carbapenemases, metallo-beta-lactamases, AmpC beta-lactamases, and extended-spectrum beta-lactamases (ESBLs). The methods presented herein include methods that permit the detection of the presence of specific beta-lactamases in bacterial samples within as few as 2 to 10 minutes.

Claims (31)

1. A method for detecting the presence of a beta-lactamase, comprising:

(a) contacting a single volume of liquid bacterial sample comprising intact bacterial cells with a solid support containing a dried form of a composition comprising an amount of a detectable beta-lactamase substrate and an amount of a lysis reagent, thereby rehydrating the composition; and

(b) detecting beta-lactamase substrate utilization in the rehydrated composition, such that a beta-lactamase is detected if the substrate has been utilized in the rehydrated composition,

wherein the amount of lysis reagent and the amount of detectable beta-lactamase substrate in the dried composition are such that after rehydration with said single volume of liquid, the concentration of the lysis reagent and the detectable beta-lactamase substrate in the rehydrated composition lyses the intact bacterial cells and the beta-lactamase is detected in the rehydrated composition.

2. A method for detecting the presence of a beta-lactamase, comprising:

(a) contacting a single volume of liquid bacterial sample comprising intact bacterial cells with a solid support containing a dried form of a composition comprising an amount of a detectable beta-lactamase substrate, an amount of a lysis reagent, and an amount of an agent that promotes the stabilization of the lysis reagent, thereby rehydrating the composition; and

(b) detecting substrate utilization in the rehydrated composition, such that a beta-lactamase is detected if the substrate has been utilized in the rehydrated composition,

wherein the amount of lysis reagent and the amount of detectable beta-lactamase substrate in the dried composition are such that after rehydration with said single volume of liquid, the concentration of the lysis reagent and the detectable beta-lactamase substrate in the rehydrated composition lyses the intact bacterial cells and the beta-lactamase is detected in the rehydrated composition.

3. A method for detecting the presence of a beta-lactamase, comprising:

(a) contacting a single volume of liquid bacterial sample comprising intact bacterial cells with a solid support containing a dried form of a composition comprising an amount of a detectable beta-lactamase substrate, an amount of a lysis reagent, an amount of a carbohydrate, and an amount of an agent that enhances the lysis of a bacterial cell by the lysis reagent, thereby rehydrating the composition; and

(b) detecting substrate utilization in the rehydrated composition, such that a beta-lactamase is detected if the substrate has been utilized in the rehydrated composition,

wherein the amount of lysis reagent and the amount of detectable beta-lactamase substrate in the dried composition are such that after rehydration with said single volume of liquid, the concentration of the lysis reagent and the detectable beta-lactamase substrate in the rehydrated composition lyses the intact bacterial cells and the beta-lactamase is detected in the rehydrated composition.

4. The method of claim 1 , wherein the dried composition further comprises an agent that enhances the lysis of a bacterial cell by the lysis reagent.

5. The method of claim 1 , wherein the dried composition further comprises one or more beta-lactamase inhibitors.

6. The method of claim 1 , wherein the lysis reagent is an enzyme.

7. The method of claim 1 , wherein the lysis reagent is lysozyme, labiase, lysostaphin, achromopeptidase or mutanolysin.

8. The method of claim 1 , wherein the detectable beta-lactamase substrate is nitrocefin, pyridinium-2-azo-p-dimethylaniline chromophore, (7R)-3-(((3-carboxy-4-nitrophenyl)thio)methyl)-8-oxo-7-(2-(thiophen-2-yl)-acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, or (7R)-7[2-aminothiazol-4-yl]-(z)-2-(1-carboxy-1-methylethoxyimino)acetamid-o)-3-(2,4-dinitrostyryl)-3-cephem-4-carboxylic acid trifluoroacetate, E-isomer.

9. The method of claim 2 , wherein the dried composition further comprises one or more beta-lactamase inhibitors.

10. The method of claim 2 , wherein the lysis reagent is an enzyme.

11. The method of claim 2 , wherein the lysis reagent is lysozyme, labiase, lysostaphin, achromopeptidase or mutanolysin.

12. The method of claim 2 , wherein the detectable beta-lactamase substrate is nitrocefin, pyridinium-2-azo-p-dimethylaniline chromophore, (7R)-3-(((3-carboxy-4-nitrophenyl)thio)methyl)-8-oxo-7-(2-(thiophen-2-yl)-acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, or (7R)-7[2-aminothiazol-4-yl]-(z)-2-(1-carboxy-1-methylethoxyimino)acetamid-o)-3-(2,4-dinitrostyryl)-3-cephem-4-carboxylic acid trifluoroacetate, E-isomer.

13. The method of claim 3 , wherein the dried composition further comprises one or more beta-lactamase inhibitors.

14. The method of claim 3 , wherein the lysis reagent is an enzyme.

15. The method of claim 3 , wherein the lysis reagent is lysozyme, labiase, lysostaphin, achromopeptidase or mutanolysin.

16. The method of claim 3 , wherein the carbohydrate is mannitol, ribose, glucose, fructose, mannose, sucrose, lactose, glycerol, Xantham gum, trehalose or a glycol.

17. The method of claim 3 , wherein the detectable beta-lactamase substrate is nitrocefin, pyridinium-2-azo-p-dimethylaniline chromophore, (7R)-3-(((3-carboxy-4-nitrophenyl)thio)methyl)-8-oxo-7-(2-(thiophen-2-yl)-acetamido)-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylic acid, or (7R)-7[2-aminothiazol-4-yl]-(z)-2-(1-carboxy-1-methylethoxyimino)acetamid-o)-3-(2,4-dinitrostyryl)-3-cephem-4-carboxylic acid trifluoroacetate, E-isomer.

18. The method of claim 3 , wherein the agent that enhances the lysis of a bacterial cell by the lysis reagent is metal chelator.

19. The method of claim 3 , wherein the lysis reagent is lysozyme, the carbohydrate is trehalose, and the agent that enhances the lysis of a bacterial cell by the lysis is EDTA.

20. The method of claim 1 , wherein the dried composition further comprises a serine beta-lactamase inhibitor in an amount sufficient to inhibit an extended-spectrum beta lactamase (ESBL) and an original-spectrum beta-lactamase (OSBL) but not a class A serine carbapenemase when said composition is rehydrated.

21. The method of claim 2 , wherein the dried composition further comprises a serine beta-lactamase inhibitor in an amount sufficient to inhibit an extended-spectrum beta lactamase (ESBL) and an original-spectrum beta-lactamase (OSBL) but not a class A serine carbapenemase when said composition is rehydrated.

22. The method of claim 3 , wherein the dried composition further comprises a serine beta-lactamase inhibitor in an amount sufficient to inhibit an extended-spectrum beta lactamase (ESBL) and an original-spectrum beta-lactamase (OSBL) but not a class A serine carbapenemase when said composition is rehydrated.

Continuity (5)
Division 13778767 · Feb 27, 2013
Division 13307426 · Nov 30, 2011
Division 12254594 · Oct 20, 2008
Provisional Application 60981156 · Oct 19, 2007
Related Publication 20160138076A1 · May 19, 2016